Kwizera Richard, Akampurira Andrew, Kandole Tadeo K, Nielsen Kirsten, Kambugu Andrew, Meya David B, Boulware David R, Rhein Joshua
Infectious Diseases Institute, College of Health Sciences, Makerere University, P.O.BOX 22418, Kampala, Uganda.
University of Minnesota, Minneapolis, Minnesota, USA.
BMC Microbiol. 2017 Aug 22;17(1):182. doi: 10.1186/s12866-017-1093-4.
Quantitative culture is the most common method to determine the fungal burden and sterility of cerebrospinal fluid (CSF) among persons with cryptococcal meningitis. A major drawback of cultures is a long turnaround-time. Recent evidence demonstrates that live and dead Cryptococcus yeasts can be distinguished using trypan blue staining. We hypothesized that trypan blue staining combined with haemocytometer counting may provide a rapid estimation of quantitative culture count and detection of CSF sterility. To test this, we evaluated 194 CSF specimens from 96 HIV-infected participants with cryptococcal meningitis in Kampala, Uganda. Cryptococcal meningitis was diagnosed by CSF cryptococcal antigen (CRAG). We stained CSF with trypan blue and quantified yeasts using a haemocytometer. We compared the haemocytometer readings versus quantitative Cryptococcus CSF cultures.
Haemocytometer counting with trypan blue staining had a sensitivity of 98% (64/65), while CSF cultures had a sensitivity of 95% (62/65) with reference to CSF CRAG for diagnostic CSF specimens. For samples that were positive in both tests, the haemocytometer had higher readings compared to culture. For diagnostic specimens, the median of log transformed counts were 5.59 (n = 64, IQR = 5.09 to 6.05) for haemocytometer and 4.98 (n = 62, IQR = 3.75 to 5.79) for culture; while the overall median counts were 5.35 (n = 189, IQR = 4.78-5.84) for haemocytometer and 3.99 (n = 151, IQR = 2.59-5.14) for cultures. The percentage agreement with culture sterility was 2.4% (1/42). Counts among non-sterile follow-up specimens had a median of 5.38 (n = 86, IQR = 4.74 to 6.03) for haemocytometer and 2.89 (n = 89, IQR = 2.11 to 4.38) for culture. At diagnosis, CSF quantitative cultures correlated with haemocytometer counts (R = 0.59, P < 0.001). At 7-14 days, quantitative cultures did not correlate with haemocytometer counts (R = 0.43, P = 0.4).
Despite a positive correlation, the haemocytometer counts with trypan blue staining did not predict the outcome of quantitative cultures in patients receiving antifungal therapy.
定量培养是确定隐球菌性脑膜炎患者脑脊液(CSF)真菌负荷和无菌状态的最常用方法。培养的一个主要缺点是周转时间长。最近的证据表明,使用台盼蓝染色可以区分活的和死的隐球菌酵母。我们假设台盼蓝染色结合血细胞计数器计数可以快速估计定量培养计数并检测脑脊液无菌状态。为了验证这一点,我们评估了乌干达坎帕拉96名感染HIV且患有隐球菌性脑膜炎的参与者的194份脑脊液样本。通过脑脊液隐球菌抗原(CRAG)诊断隐球菌性脑膜炎。我们用台盼蓝对脑脊液进行染色,并使用血细胞计数器对酵母进行定量。我们将血细胞计数器读数与脑脊液隐球菌定量培养结果进行了比较。
对于诊断性脑脊液样本,与脑脊液CRAG相比,台盼蓝染色结合血细胞计数器计数的灵敏度为98%(64/65),而脑脊液培养的灵敏度为95%(62/65)。对于两项检测均呈阳性的样本,血细胞计数器的读数高于培养结果。对于诊断性样本,血细胞计数器对数转换计数的中位数为5.59(n = 64,IQR = 5.09至6.05),培养的中位数为4.98(n = 62,IQR = 3.75至5.79);而总体中位数计数,血细胞计数器为5.35(n = 189,IQR = 4.78 - 5.84),培养为3.99(n = 151,IQR = 2.59 - 5.14)。与培养无菌状态的一致性百分比为2.4%(1/42)。非无菌随访样本中,血细胞计数器计数的中位数为5.38(n = 86,IQR = 4.74至6.03),培养的中位数为2.89(n = 89,IQR = 2.11至4.38)。在诊断时,脑脊液定量培养与血细胞计数器计数相关(R = 0.59,P < 0.001)。在7 - 14天,定量培养与血细胞计数器计数不相关(R = 0.43,P = 0.4)。
尽管存在正相关,但台盼蓝染色结合血细胞计数器计数并不能预测接受抗真菌治疗患者的定量培养结果。